RAS or FLT3-ITD mutations have been associated with high levels of ROS in AML, although this association is not specific to these mutant genes and higher levels of ROS have been correlated with other oncogene driver mutations in myeloid malignancies[105,110]. The gene discussed is FLT3; the disease is acute myeloid leukemia.